LC
ONC

Lindbrook Capital’s BeOne Medicines Ltd ONC Stock Holding History

Lindbrook Capital’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$58.8K Sell
216
-3
-1% -$701 0.01% 926
2024
Q4 		$40.5K Buy
219
+12
+6% +$2.45K ﹤0.01% 908
2024
Q3 		$46.5K Hold
207
– – ﹤0.01% 856
2024
Q2 		$29.5K Hold
207
– – ﹤0.01% 1029
2024
Q1 		$32.4K Hold
207
– – ﹤0.01% 973
2023
Q4 		$37.3K Hold
207
– – ﹤0.01% 871
2023
Q3 		$37.2K Hold
207
– – ﹤0.01% 792
2023
Q2 		$36.9K Hold
207
– – ﹤0.01% 818
2023
Q1 		$44.6K Hold
207
– – 0.01% 738
2022
Q4 		$45.5K Hold
207
– – 0.01% 733
2022
Q3 		$28K Hold
207
– – ﹤0.01% 851
2022
Q2 		$34K Hold
207
– – 0.01% 796
2022
Q1 		$39K Sell
207
-75
-27% -$15.9K 0.01% 762
2021
Q4 		$76K Sell
282
-32
-10% -$10.8K 0.01% 581
2021
Q3 		$114K Buy
314
+11
+4% +$3.6K 0.03% 246
2021
Q2 		$104K Buy
303
+3
+1% +$994 0.02% 284
2021
Q1 		$104K Hold
300
– – 0.02% 267
2020
Q4 		$78K Sell
300
-20
-6% -$5.51K 0.02% 290
2020
Q3 		$92K Buy
320
+56
+21% +$13.2K 0.03% 225
2020
Q2 		$50K Buy
264
+222
+529% +$36.1K 0.01% 361
2020
Q1 		$5K Buy
+42
New +$6.57K ﹤0.01% 1035
2019
Q4 		– Sell
-55
Closed -$7K – 1557
2019
Q3 		$7K Hold
55
– – ﹤0.01% 1007
2019
Q2 		$6K Buy
55
+8
+17% +$1.01K ﹤0.01% 1030
2019
Q1 		$6K Buy
+47
New +$6.34K ﹤0.01% 1049

Other funds holding ONC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Lindbrook Capital's ONC Position: Q1 2025 in Review

Lindbrook Capital reduced its BeOne Medicines Ltd (ONC) stake by 1.4% in Q1 2025, selling an estimated $701 and leaving 216 shares worth $58.8K. The position accounts for 0.01% of the portfolio, ranked #926.

Lindbrook Capital first reported a position in ONC in Q1 2019 and has held it in 24 quarters since. The position peaked at $114K in Q3 2021. 267 funds tracked by Wall St. Rank hold ONC as of Q1 2025.

  • Lindbrook Capital held 216 shares of BeOne Medicines Ltd worth $58.8K as of Q1 2025.
  • Lindbrook Capital sold 3 BeOne Medicines Ltd shares in Q1 2025, an estimated $701.
  • BeOne Medicines Ltd made up 0.01% of Lindbrook Capital's portfolio in Q1 2025, its #926 holding.
  • Lindbrook Capital first reported a position in BeOne Medicines Ltd in Q1 2019 and has held it in 24 quarters since.
  • Lindbrook Capital's BeOne Medicines Ltd position peaked at $114K in Q3 2021.
  • 267 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q1 2025.

Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.